Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Seattle, Washington 98104


Purpose:

This is a randomized, double blind, placebo controlled, parallel group study of MAP0004 in adult migraineurs. Subjects will self administer study drug in the outpatient setting.


Criteria:

Major Inclusion Criteria: - Male or female between 18 and 65 years of age. - History of episodic, acute migraine (with or without aura) with onset prior to 50 Major Exclusion Criteria: - Known allergy or sensitivity or contraindication to study drugs or their formulations - History of chronic pulmonary disease, coronary artery disease (CAD),liver disease, kidney disease,seizures, stroke,or major psychiatric condition. - Any condition that, in the opinion of the Investigator, would make the subject unsuitable for study participation


NCT ID:

NCT00623636


Primary Contact:

Study Director
Shashidhar H Kori, MD
MAP Pharmaceuticals Medical Monitor


Backup Contact:

N/A


Location Contact:

Seattle, Washington 98104
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.